Dolphin Medical Services share price
BSE: 526504Healthcare ServicesSmall Cap
Last close ₹6.54up ₹0.23 (3.65%)
Share price at the BSE close on 19 Oct 2026. Previous close ₹6.31.
52-week range of traded prices to 19 Oct 2026
₹1.99Low, 3 Nov 2025₹9.57High, 6 Jul 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9.88 Cr4,792nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 16 May 2026
- 1.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 16 May 2026
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day.
- 10,615
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026Filed 14 Aug
- Revenue
- ₹0.21 Cr
- Net profit
- ₹0.02 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 8.6%
Revenue by year
Peak revenue ₹0.78 Cr, year to Mar 2025
Net profit by year, a loss in red
- Net profit
- Loss
Back to profit in the year to Mar 2026, ₹0.04 CrA loss in 9 of the 10 years shown
| ₹ crore | Sep 2024Filed 12 Nov | Dec 2024Filed 10 Feb | Mar 2025Filed 10 Jun | Jun 2025Filed 26 Jul | Sep 2025Filed 11 Nov | Dec 2025Filed 6 Feb | Mar 2026 | Jun 2026Filed 14 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.25 | 0.24 | 0.14 | 0.17 | 0.18 | 0.21 | – | 0.21 |
| Net profit | 0.02 | 0.01 | −0.07 | 0.03 | 0.01 | 0.02 | – | 0.02 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 7.7% | 2.8% | −48.8% | 18.6% | 3.3% | 8.2% | – | 8.6% |
Standalone. The last eight quarters. The latest is shaded. No results on record for the quarter to Mar 2026.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare Service Provider, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +117.9% | – | – | 0.0% |
| 3 years | +45.9% | – | – | 0.0% |
| 5 years | +26.8% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Healthcare Service Provider, 36 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Dolphin Medical Services in market cap. Dolphin Medical Services's own figures are from its last trade, on 19 Oct 2026.
Dolphin Medical Services is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Tejnaksh HealthcareTEJNAKSH | 24 | 19.2 | 0.9 | 7.6 | −13.0% | −37.0% | 4.7% | 5.2% | 0.00% |
 Transgene BiotekTRABI | 19 | – | 2.3 | – | −15.0% | – | −17.5% | −2.6% | 0.00% |
 Nidan Laboratories and HealthcareNIDAN | 17 | 11.4 | 0.2 | – | +4.1% | −23.8% | 2.2% | – | 0.00% |
 Family Care HospitalsFAMILYCARE | 11 | – | 1.1 | – | −93.9% | – | −73.4% | −27.5% | 0.00% |
 Dhanvantri Jeevan RekhaZDHJERK | 10 | – | 0.9 | 5.7 | +49.9% | – | – | 1.9% | 0.00% |
 Looks Health ServicesLOOKS | 8 | 343.4 | 0.6 | 40.6 | −5.1% | −69.0% | 0.2% | 0.2% | 0.00% |
 Boston Commerce531458 | 7 | – | – | – | – | – | – | – | 0.00% |
 Dr Lalchandani LabsDLCL | 6 | 94.7 | 0.4 | – | −6.0% | −84.8% | 0.5% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
21 Sep · Board meeting
Meeting on 21 Sep 2026
Dolphin Medical Services share price by year
Each calendar year to 2025.Dolphin Medical Services share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 2.87 | +0.3% | 2.87 | 2.05 |
| 2024 | 2.86 | +45.9% | 3.15 | 1.81 |
| 2023 | 1.96 | +12.0% | 1.96 | 1.42 |
| 2022 | 1.75 | −36.8% | 3.19 | 1.53 |
| 2021 | 2.77 | +38.5% | 5.41 | 1.45 |
| 2020 | 2.00 | +412.8% | 2.28 | 0.40 |
| 2019 | 0.39 | −52.4% | 1.39 | 0.39 |
| 2018 | 0.82 | −52.9% | 2.01 | 0.80 |
| 2017 | 1.74 | +33.8% | 2.22 | 0.95 |
| 2016 | 1.30 | +20.4% | 1.36 | 0.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The last 10 trading days to 19 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | 6.05 | 6.57 | 6.05 | 6.54 | 6.23 | 10,615 |
| 12 Oct 2026 | 6.35 | 6.90 | 6.30 | 6.31 | 6.32 | 64,571 |
| 5 Oct 2026 | 6.94 | 6.94 | 6.31 | 6.63 | 6.84 | 29,493 |
| 28 Sep 2026 | 6.61 | 6.61 | 6.30 | 6.61 | 6.61 | 32,850 |
| 21 Sep 2026 | 6.06 | 6.30 | 5.90 | 6.30 | 6.26 | 45,156 |
| 15 Sep 2026 | 6.31 | 6.62 | 6.00 | 6.00 | 6.08 | 55,851 |
| 7 Sep 2026 | 6.93 | 6.93 | 6.31 | 6.31 | 6.32 | 77,486 |
| 31 Aug 2026 | 7.32 | 7.32 | 6.64 | 6.64 | 6.65 | 32,841 |
| 24 Aug 2026 | 6.92 | 7.20 | 6.92 | 6.98 | 7.01 | 68,190 |
| 17 Aug 2026 | 7.86 | 7.86 | 7.15 | 7.20 | 7.41 | 1,51,900 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Dolphin Medical Services Ltd.
- BSE code
- 526504
- ISIN
- INE796B01013
- Industry
- Healthcare Services
- Listed
- Jul 1994
- Face value
- ₹10
- CIN
- L24239TG1992PLC014775
- Corporate identity number, the registrar of companies' code for it